Skip to main content
Top
Published in: BMC Health Services Research 1/2014

Open Access 01-12-2014 | Research article

What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?

Authors: Katharine M Wells, Matthew J Boyd, Tracey Thornley, Helen F Boardman

Published in: BMC Health Services Research | Issue 1/2014

Login to get access

Abstract

Background

The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service. This assumption is based on a theoretical calculation. This study aimed to find out the actual proportion of prescription items eligible for the NMS dispensed in community pharmacies in order to compare this with the theoretical assumption. The study also aimed to investigate whether the proportion of prescription items eligible for the NMS is affected by pharmacies’ proximity to GP practices.

Methods

The study collected data from eight pharmacies in Nottingham belonging to the same large chain of pharmacies. Pharmacies were grouped by distance from the nearest GP practice and sampled to reflect the distribution by distance of all pharmacies in Nottingham. Data on one thousand consecutive prescription items were collected from each pharmacy and the number of NMS eligible items recorded. All NHS prescriptions were included in the sample. Data were analysed and proportions calculated with 95% confidence intervals used to compare the study results against the theoretical figure of 0.5% of prescription items being eligible for the NMS.

Results

A total of 8005 prescription items were collected (a minimum of 1000 items per pharmacy) of which 17 items were eligible to receive the service. The study found that 0.25% (95% confidence intervals: 0.14% to 0.36%) of prescription items were eligible for the NMS which differs significantly from the theoretical assumption of 0.5%. The opportunity rate for the service was lower, 0.21% (95% confidence intervals: 0.10% to 0.32%) of items, as some items eligible for the NMS did not translate into opportunities to offer the service. Of all the prescription items collected in the pharmacies, 28% were collected by patient representatives.

Conclusions

The results of this study show that the proportion of items eligible for the NMS dispensed in community pharmacies is lower than the Department of Health assumption of 0.5%. This study did not find a significant difference in the rate of NMS opportunities between pharmacies located close to GP practices compared to those further away.
Literature
2.
go back to reference Latif A, Boardman H: Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008, 30: 536-543. 10.1007/s11096-008-9203-x.CrossRefPubMed Latif A, Boardman H: Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008, 30: 536-543. 10.1007/s11096-008-9203-x.CrossRefPubMed
3.
go back to reference Gale A, Watson MC: The provision of current and future sexual health services from community pharmacies in Grampian, Scotland. Int J Clin Pharmacol. 2011, 33: 183-190. 10.1007/s11096-010-9458-x.CrossRef Gale A, Watson MC: The provision of current and future sexual health services from community pharmacies in Grampian, Scotland. Int J Clin Pharmacol. 2011, 33: 183-190. 10.1007/s11096-010-9458-x.CrossRef
4.
go back to reference Newlands RS, Watson MC, Lee AJ: The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: a survey of community pharmacists’ attitudes, practice and future possibilities. Int J Pharm Pract. 2011, 19: 106-114.CrossRefPubMed Newlands RS, Watson MC, Lee AJ: The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: a survey of community pharmacists’ attitudes, practice and future possibilities. Int J Pharm Pract. 2011, 19: 106-114.CrossRefPubMed
5.
go back to reference Uosukainen H, Bell JS, Laitinen K, Tacke U, Ilomaki J, Turunen JHO: First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland. Int J Drug Policy. 2013, 24: 492-497. 10.1016/j.drugpo.2013.02.004.CrossRefPubMed Uosukainen H, Bell JS, Laitinen K, Tacke U, Ilomaki J, Turunen JHO: First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland. Int J Drug Policy. 2013, 24: 492-497. 10.1016/j.drugpo.2013.02.004.CrossRefPubMed
6.
go back to reference Wells KM, Thornley T, Boyd MJ, Boardman HF: Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Res Social Adm Pharm. 2014, 10: 58-71. 10.1016/j.sapharm.2013.03.003.CrossRefPubMed Wells KM, Thornley T, Boyd MJ, Boardman HF: Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Res Social Adm Pharm. 2014, 10: 58-71. 10.1016/j.sapharm.2013.03.003.CrossRefPubMed
9.
go back to reference Bland M: An Introduction to Medical Statistics. 1995, Oxford: Oxford Medical Publications, 123-126-141-147. 2 Bland M: An Introduction to Medical Statistics. 1995, Oxford: Oxford Medical Publications, 123-126-141-147. 2
12.
go back to reference Faulkner B: Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2010, 25: 1219-1224. 10.1007/s00467-009-1200-3.CrossRef Faulkner B: Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2010, 25: 1219-1224. 10.1007/s00467-009-1200-3.CrossRef
14.
go back to reference Latif A, Pollock K, Boardman HF: Why do patients accept or decline the invitation for a Medicines Use Review?. Int J Pharm Pract. 2010, 18 (Suppl 2): 21. Latif A, Pollock K, Boardman HF: Why do patients accept or decline the invitation for a Medicines Use Review?. Int J Pharm Pract. 2010, 18 (Suppl 2): 21.
16.
go back to reference McElnay JC, Nicholl AJ, Grainger-Rousseau TJ: The role of the community pharmacist – a survey of public opinion in Northern Ireland. Int J Pharm Pract. 1993, 2: 95-100. 10.1111/j.2042-7174.1993.tb00733.x.CrossRef McElnay JC, Nicholl AJ, Grainger-Rousseau TJ: The role of the community pharmacist – a survey of public opinion in Northern Ireland. Int J Pharm Pract. 1993, 2: 95-100. 10.1111/j.2042-7174.1993.tb00733.x.CrossRef
17.
go back to reference Seston L, Nicolson M, Hassell K, Cantrill J, Noyce P: Variation in the incidence, presentation and management of nine minor ailments in community pharmacy. Pharm J. 2001, 266: 429-432. Seston L, Nicolson M, Hassell K, Cantrill J, Noyce P: Variation in the incidence, presentation and management of nine minor ailments in community pharmacy. Pharm J. 2001, 266: 429-432.
18.
go back to reference Bennett EV, Jones IF: Investigating health information requests in six community pharmacies. Pharm J. 2000, 265: R45. Bennett EV, Jones IF: Investigating health information requests in six community pharmacies. Pharm J. 2000, 265: R45.
Metadata
Title
What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?
Authors
Katharine M Wells
Matthew J Boyd
Tracey Thornley
Helen F Boardman
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2014
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-14-115

Other articles of this Issue 1/2014

BMC Health Services Research 1/2014 Go to the issue